| 摘要 |
Disclosed is a method for treating or preventing joint damage in a subject with early rheumatoid arthritis (RA) or incipient RA, the method comprising, consisting or consisting essentially of eliciting an antigen specific tolerogenic response to an aggrecan polypeptide in the subject, thereby treating or preventing the joint damage. |
